Associated Papers
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Yen I et al.
Nature, 2021
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors.
Monaco KA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
Somatic activating ARAF mutations in Langerhans cell histiocytosis.
Nelson DS et al.
Blood, 2014
ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.
Rebocho AP et al.
Oncogene, 2013
Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription.
Rauch J et al.
Cancer Research, 2010
Select a paper to view details